Most Recent
Johnson & Johnson asks High Court to review landmark pelvic mesh ruling
Product Liability 2021-04-09 2:29 pm By Cat Fredenburgh

A Johnson & Johnson unit wants the High Court to review the Full Federal Court’s rejection of its challenge to a landmark class action ruling that found the company’s pelvic mesh implants were defective and that it failed to adequately warn about their risks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

J&J unit hit with second class action over pelvic mesh products
Class Actions 2021-04-07 9:06 pm By Cat Fredenburgh

Johnson & Johnson’s Ethicon unit is facing a second class action over its allegedly defective pelvic mesh products, following a landmark ruling that found the drug company did not adequately warn about the devices’ risks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Boston Scientific hit with second class action over pelvic mesh products
Class Actions 2021-03-22 11:36 am By Cat Fredenburgh

Boston Scientific has been hit with second class action on behalf of women who were implanted with allegedly defective pelvic mesh devices, just two weeks after the Full Court tossed an appeal to a landmark ruling that put Johnson & Johnson on the hook for millions in damages for failing to adequately warn patients about the risks the products carry.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Johnson & Johnson unit loses high-stakes appeal in pelvic mesh class action
Appeals 2021-03-05 11:34 am By Miklos Bolza

The Full Federal Court has tossed an appeal by Johnson & Johnson unit Ethicon challenging a landmark decision that put it on the hook for paying damages to 10,000 women who suffered injury through defects in its prolapse mesh and incontinence tape implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pelvic mesh maker Astora may make admissions in class action in light of J&J case
Product Liability 2021-02-26 2:19 pm By Miklos Bolza

Pelvic mesh device maker Astora Women’s Health is weighing whether to make admissions in a class action over allegedly defective products in light of a similar, high profile class action brought against Johnson & Johnson unit Ethicon over the devices.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

J&J slammed for ‘wreckage’ of a case in pelvic mesh class action appeal
Class Actions 2021-02-03 3:39 pm By Miklos Bolza

A group of women harmed by pelvic mesh devices produced by Johnson & Johnson have accused it of persisting with a “wreckage” of a case in which one of its own doctors admitted the pharmaceutical company knew of the risks posed by the implants at they time they were sold worldwide.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge was wrong to ignore pelvic mesh doctors, J&J says in high-stakes appeal
Appeals 2021-02-01 6:53 pm By Miklos Bolza

The judge who found J&J’s pelvic mesh implants defective in a high stakes class action ruling mde a “pervasive error” in disregarding the knowledge and views of the applicants’ doctors, an appeals court has heard. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

J&J ordered to pay $40M in pelvic mesh class action costs as stay bid tossed by court
Product Liability 2020-12-21 1:03 pm By Christine Caulfield

A unit of Johnson & Johnson has been ordered to pay around $40 million in legal costs to the lead applicants in a class action over pelvic mesh implants after a judge dismissed the company’s bid to stay the costs until after a high profile appeal is heard next year.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judges unclear about Johnson & Johnson unit’s arguments in pelvic mesh appeal
Appeals 2020-10-23 2:57 pm By Miklos Bolza

A judge due to hear a high profile appeal by Johnson & Johnson unit Ethicon has expressed confusion about the grounds on which the medical device maker is challenging a landmark judgment putting it on the hook for potentially hundreds of million of dollars in damages over faulty pelvic mesh implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Janssen to expand patent case against Juno over generic HIV drug
Intellectual Property 2020-07-01 4:40 pm By Miklos Bolza

Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno’s plans to launch a generic version of the drug threaten another one of its patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?